It is well known that the cytogenetic risk categories of currently available prognostic scoring systems for de novo MDS (IPSS and IPSS‐R) are highly significant factors for the prognosis of MDS.
← all excerpts
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.
1
—
—